New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 5, 2013
08:09 EDTMDASMedAssets pullback brings attractive entry point, says Lazard Capital
Lazard Capital says the recent pullback in shares of MedAssets provides an attractive entry point as it does not see any change in the company's fundamentals. The firm reiterates a Buy rating on the name with a $22 price target.
News For MDAS From The Last 14 Days
Check below for free stories on MDAS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 15, 2014
10:00 EDTMDASOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
April 14, 2014
16:54 EDTMDASMedAssets reinstated with an Outperform at Raymond James
Raymond James reinstated coverage of MedAssets with an Outperform rating and $27 price target, up from its previous rating of Market Perform.
April 11, 2014
07:52 EDTMDASMedAssets remains top pick in health IT space, says RW Baird
Subscribe for More Information
April 9, 2014
10:06 EDTMDASOn The Fly: Analyst Initiation Summary
Subscribe for More Information
06:09 EDTMDASMedAssets initiated with a Neutral at SunTrust
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use